David McManus to Anti-Arrhythmia Agents
This is a "connection" page, showing publications David McManus has written about Anti-Arrhythmia Agents.
Connection Strength
1.099
-
Walkey AJ, McManus D. When Rhythm Changes Cause the Blues: New-Onset Atrial Fibrillation during Sepsis. Am J Respir Crit Care Med. 2017 01 15; 195(2):152-154.
Score: 0.511
-
Shaikh AY, Maan A, Heist EK, Tighe DA, Aurigemma GP, McManus DD. Management strategies in atrial fibrillation in patients with heart failure. Cardiol Rev. 2012 Nov-Dec; 20(6):288-96.
Score: 0.382
-
Maan A, Mansour M, McManus DD, Patel VV, Cheng A, Ruskin JN, Heist EK. Novel therapeutic targets in the management of atrial fibrillation. Am J Cardiovasc Drugs. 2014 Dec; 14(6):403-21.
Score: 0.110
-
Athreya DS, Saczynski JS, Gurwitz JH, Monahan KM, Bamgbade BA, Paul TJ, Sogade F, Lessard DM, McManus DD, Helm RH. Cognitive impairment and treatment strategy for atrial fibrillation in older adults: The SAGE-AF study. J Am Geriatr Soc. 2024 Jul; 72(7):2082-2090.
Score: 0.053
-
Bosch NA, Rucci JM, Massaro JM, Winter MR, Quinn EK, Chon KH, McManus DD, Walkey AJ. Comparative Effectiveness of Heart Rate Control Medications for the Treatment of Sepsis-Associated Atrial Fibrillation. Chest. 2021 04; 159(4):1452-1459.
Score: 0.042